ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@Roche ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @Roche ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
Cancer treatment has come a long way with cancer immunotherapy being the latest area of
#innovation. Learn more!http://ow.ly/vOBJ3091gB7 -
People in Europe with ALK-positive
#lungcancer now have a potential new treatment option. http://ow.ly/9KjB309cnS8$ROG$RHHBYpic.twitter.com/UPtgtZFEr1
-
Empowering clinicians and women to make informed decisions throughout every stage of
#pregnancy: http://ow.ly/EHBO3096rN3 .#FamilyPlanningpic.twitter.com/7WsgW1P6Mf
-
Our new treatment for people with a type of
#lungcancer has been approved for use in Europe. http://ow.ly/B3N2309cnJ5$ROG$RHHBY#pharmapic.twitter.com/HirKnZnJY0
-
#Media: AMH testing can guide personalised fertility treatments: http://ow.ly/31MG3099ZN8 .#CDxpic.twitter.com/YtzUQNnezQ
-
Explore the role antibodies play in medicine: http://ow.ly/lo123091g6k
#health -
EU approves our treatment for people with previously treated ALK-positive non-small cell
#lungcancer. http://ow.ly/1ntp309cmVf$ROG$RHHBYpic.twitter.com/PBZIbFceCs
-
Clinical trials are essential to determine whether new drugs or diagnostics are both safe and effective. Learn more: http://ow.ly/vyys3091eyg
-
We are "Doing now what patients need next". Read more: http://ow.ly/K4ak309b36t pic.twitter.com/ww3DD5DxME
-
We are helping clinicians to advise the course of
#fertility treatments: http://ow.ly/RUDE3096r32 .#IVFpic.twitter.com/MTCAc2yBeo
-
Explore our employee's perspectives on our company's purpose: http://ow.ly/T3dH309afJe
#GreatPlaceToWork -
Roche launches the first companion diagnostic solution in the
#fertility area: http://ow.ly/XRQF3099ZGF .$RHHBY$ROGpic.twitter.com/Rwsj7W3AMX
-
Read how we’re partnering in
#Africa to address barriers at every step of the patient journey: http://ow.ly/qiVD3095O0K pic.twitter.com/HYohpohWOf
-
Digitisation reshapes our lives, impacting
#healthcare too. Learn how we use this trend to improve patient's lives:http://ow.ly/SJYX3091f22 -
Phase 2 study results of our
#immunotherapy combination in advanced renal cancer presented at#GU17. http://ow.ly/xIvR3097Otz pic.twitter.com/oHUXxGCmbY
-
At
#GU17? Don’t forget to check out General Session 9 this afternoon http://ow.ly/AKjz307GrlY .#immunoonc#renalcellcarcinoma -
#bladdercancer diagnosed in advanced stages is associated with a poor prognosis. http://ow.ly/MXYN308WZTp#blcsmpic.twitter.com/Bh4OwZOw3M
-
Our
#immunotherapy combo shows potential in Phase 2 study for certain people with advanced kidney cancer. http://ow.ly/WOgG3097OsS#GU17pic.twitter.com/Lb6EvC4hUd
-
For those at
#GU17 this morning, head to Poster Session C on#renalcellcarcinoma. http://ow.ly/EuOD307Gr8O#immunoonc -
#Renalcellcarcinoma represents 9 out of 10 cases of kidney cancer. http://ow.ly/nCgv308WZrL#kcsmpic.twitter.com/RsPUINqwp8
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.
Roche